Acne that develops during JAK inhibitor treatment can often be managed with skin treatments such as benzoyl peroxide, azelaic acid, or prescription acne medication. Many people can continue their JAK inhibitor while treating the breakouts. The best approach depends on the type of skin changes, how troublesome they are, and the medication being used.
JAK inhibitors are medicines that reduce certain signals involved in inflammation. They are used for conditions such as eczema (atopic dermatitis), rheumatoid arthritis, and some other inflammatory diseases. Although these medicines can improve the condition they are prescribed for, acne or acne-like bumps may occur as a side effect.
Can JAK Inhibitors Cause Acne?
Yes. Acne is a recognized side effect of some JAK inhibitors, particularly oral medicines used to treat atopic dermatitis.
A systematic review published in JAMA Dermatology examined 25 randomized clinical trials involving 10,839 participants. Researchers found that JAK inhibitor treatment was associated with approximately 3.8 times higher odds of acne compared with placebo. This finding describes an association across the trials and does not mean that everyone taking these medicines will develop acne.
JAK inhibitors work by blocking enzymes called Janus kinases, which help carry signals between cells. Blocking these signals can reduce unwanted inflammation. However, skin changes can occur during treatment, and the precise reasons for JAK inhibitor-associated acne are not fully established.
Which JAK inhibitors are linked to acne?
Acne has been reported with several JAK inhibitors, including:
- Upadacitinib (Rinvoq): Acne is a documented adverse reaction, particularly in studies involving patients with atopic dermatitis.
- Abrocitinib (Cibinqo): Acne has also been reported during treatment for atopic dermatitis.
- Other JAK inhibitors: Acne-like skin changes have been reported with some other medicines in this class, although the frequency and supporting evidence differ between drugs.
The official prescribing information available through the U.S. National Library of Medicine's DailyMed database reports acne in 10% of patients receiving upadacitinib 15 mg and 16% receiving 30 mg during the first 16 weeks of certain atopic dermatitis trials, compared with 2% receiving placebo. These figures apply to the specific clinical trials and should not be treated as the expected risk for every patient or condition.
Reports suggest that acne may be more frequent with higher doses of certain JAK inhibitors. However, treatment decisions must consider the condition being treated and the medicine's overall benefits and risks, not acne alone.
What Does JAK Inhibitor-Related Acne Look Like?
Skin changes associated with JAK inhibitors may resemble ordinary acne, but not every outbreak has the same appearance.
Possible features include:
- Small red or inflamed bumps, particularly on the face.
- Pimples containing a small amount of pus.
- Breakouts affecting the forehead or cheeks.
- Occasional acne-like lesions on other areas of the body.
- Skin redness or irritation accompanying the bumps.
Some eruptions resemble acne without having the blocked pores, blackheads, or whiteheads commonly seen in ordinary acne. These may have features similar to rosacea, another inflammatory skin condition.
This distinction matters because acne, rosacea-like eruptions, and folliculitis (inflammation of hair follicles) may need different treatments.
A dermatologist can assess the appearance and distribution of the lesions, when they developed, previous skin problems, and whether they appeared after starting or changing a medication.
Which Acne Treatments Work During JAK Inhibitor Therapy?
Several established acne treatments may be considered for people who develop breakouts while taking a JAK inhibitor. Direct research comparing treatments specifically for JAK inhibitor-associated acne remains limited, so clinicians often adapt approaches used for ordinary acne or similar inflammatory eruptions.
1. Benzoyl peroxide for inflamed pimples
Benzoyl peroxide is a commonly used acne treatment that reduces acne-associated bacteria on the skin. It is available in washes, creams, and gels.
The American Academy of Dermatology identifies benzoyl peroxide as an effective acne treatment and notes that it is often used alongside other medicines that address different causes of acne.
For someone receiving a JAK inhibitor, a dermatologist may consider benzoyl peroxide when the eruption resembles inflammatory acne.
Potential disadvantages include dryness, redness, peeling, and irritation. Benzoyl peroxide can also bleach towels and clothing.
People with eczema or sensitive skin may need a particularly gentle approach because irritating acne treatments can make existing skin discomfort worse.
2. Azelaic acid for bumps and lingering marks
Azelaic acid is another topical option that may be useful for acne-like breakouts. It helps reduce inflammation and can address acne-associated bacteria and clogged pores.
It may be especially worth discussing when inflamed bumps occur alongside redness or dark marks left after pimples heal.
Azelaic acid can cause temporary stinging, burning, or irritation, especially when first introduced. The choice of formulation and frequency of application should take the person's skin sensitivity into account.
For patients with underlying eczema, clinicians may prefer a carefully selected topical treatment rather than introducing several potentially irritating products at once.
3. Topical retinoids for clogged pores
Topical retinoids, including adapalene and tretinoin, are established treatments for ordinary acne. They help prevent clogged pores and may improve blackheads, whiteheads, and inflammatory pimples.
Retinoids can be useful when a person taking a JAK inhibitor also has conventional acne. However, they may not be equally helpful for every acne-like eruption associated with these medicines.
Dryness, peeling, and irritation can limit their use, especially when the skin barrier is already affected by eczema.
A dermatologist may recommend gradually introducing a retinoid or using a different treatment when irritation is a concern. Topical retinoids should generally be avoided during pregnancy or when planning pregnancy unless a qualified clinician provides specific advice.
4. Prescription antibiotics for more persistent inflammatory acne
If topical treatments are insufficient, a dermatologist may consider prescription antibiotics such as doxycycline for selected patients with inflammatory acne.
The American Academy of Dermatology's acne guidelines support oral doxycycline for appropriate acne cases. They also emphasize limiting systemic antibiotic use and combining antibiotics with other acne treatments, including benzoyl peroxide, to help reduce antibiotic resistance.
Antibiotics are not necessary for every breakout associated with JAK inhibitor treatment. A clinician should first consider whether the skin eruption is acne, a rosacea-like reaction, folliculitis, or another condition.
Because JAK inhibitors can affect immune function and increase susceptibility to certain infections, new or unusual skin lesions deserve appropriate clinical assessment before antibiotic treatment is started.
5. Isotretinoin for difficult-to-control acne
Oral isotretinoin is an effective prescription medicine for severe acne, acne that causes scarring, or acne that has not responded to standard treatment.
It is not usually the first choice for uncomplicated acne-like breakouts during JAK inhibitor therapy.
For patients with persistent, extensive, or scarring acne, a dermatologist may evaluate whether isotretinoin is appropriate. Treatment requires medical supervision because of important adverse effects and monitoring requirements.
Isotretinoin can cause serious harm to a developing fetus and must not be used during pregnancy. Strict pregnancy-prevention precautions apply to patients who can become pregnant.
The decision to combine isotretinoin with an existing JAK inhibitor requires individualized review of potential risks, other medications, and monitoring needs.
Do You Need to Stop Your JAK Inhibitor Because of Acne?
Not necessarily. Many acne-like eruptions can be managed without stopping the JAK inhibitor responsible for controlling the underlying inflammatory condition.
Continuing treatment may be reasonable when the skin changes are manageable and the medicine is providing important benefits. However, the decision depends on clinical assessment rather than the appearance of acne alone.
A healthcare professional may consider:
- How well the JAK inhibitor is controlling the original condition.
- The extent, discomfort, and persistence of the breakout.
- Whether topical acne treatments have helped.
- Whether the eruption is actually acne or another skin problem.
- Other medication risks, medical conditions, and available treatment alternatives.
If acne is unusually troublesome or continues despite suitable treatment, the prescribing specialist may reassess the overall medication plan.
Do not reduce the dose, skip doses, or discontinue a prescribed JAK inhibitor solely because acne has appeared without first speaking to the clinician managing the treatment.
How to Build a Gentle Skin-Care Routine
Medication is only one part of managing acne during JAK inhibitor therapy. A consistent skin-care routine can help reduce irritation and make prescribed treatments easier to tolerate.
Morning routine
Begin with a gentle, fragrance-free cleanser rather than a harsh exfoliating wash. Follow with a non-comedogenic moisturizer, meaning one formulated to avoid clogging pores.
Apply any prescribed morning acne treatment as directed. Finish with broad-spectrum sunscreen with SPF 30 or higher, particularly when using medications that can make the skin more sensitive.
Evening routine
Wash the skin gently to remove sunscreen, dirt, and excess oil. Apply prescribed acne medication according to the clinician's instructions and use a suitable moisturizer.
People with eczema may need adjustments to protect areas where the skin is inflamed or unusually sensitive.
Avoid scrubbing the face, squeezing pimples, or layering multiple strong acne products without guidance. These practices can worsen irritation without improving treatment results.
How Long Does It Take for Acne Treatment to Work?
Acne treatment usually takes time. Some people notice improvement within several weeks, but a more meaningful assessment of a treatment plan often requires around 8 to 12 weeks.
This is a general acne-treatment timeframe rather than a proven timeline specifically for JAK inhibitor-associated acne.
The American Academy of Family Physicians summarizes evidence-based acne management, including topical combinations, appropriate antibiotic use, and options for difficult-to-treat acne.
A clinician may review progress after an initial treatment period and adjust the regimen if the breakout is not improving or the skin is becoming irritated.
Regular photographs taken under similar lighting may help patients describe changes at follow-up appointments, although they cannot replace a clinical examination.
When Should You Contact Your Dermatologist?
Arrange a medical review if acne begins after starting a JAK inhibitor and becomes persistent, painful, widespread, or difficult to manage. Early assessment is particularly useful when lesions are leaving scars or significantly affecting daily life.
Contact your prescribing clinician promptly if new skin lesions appear alongside signs that could suggest infection, such as increasing warmth, spreading redness, significant tenderness, pus, or fever.
JAK inhibitors carry important warnings about serious infections and other potential adverse effects. A new rash or skin eruption should not automatically be assumed to be ordinary acne.
A dermatologist can assess the skin findings while the prescribing specialist considers the safety and effectiveness of the ongoing JAK inhibitor treatment.
Can JAK Inhibitor-Related Acne Be Prevented?
There is currently no established skin-care routine proven to prevent all acne associated with JAK inhibitors.
Nevertheless, gentle cleansing, regular moisturizing, and early attention to new breakouts may help patients maintain comfortable skin and avoid unnecessary irritation.
People with a history of acne or particularly sensitive skin can discuss this before beginning JAK inhibitor treatment. The clinician may recommend a suitable skin-care plan and explain which changes should be reported during follow-up.
Preventive prescription acne treatment is not automatically required for everyone starting a JAK inhibitor.
Choosing the Right Treatment Approach
The most useful treatment depends on what the skin eruption actually represents.
For small inflammatory pimples, benzoyl peroxide or azelaic acid may be reasonable options. When clogged pores are prominent, a topical retinoid may be considered. More persistent or extensive inflammatory acne may require prescription treatment, while difficult or scarring cases need specialist assessment.
These options are supported mainly by established acne-management evidence, with more limited research focused specifically on JAK inhibitor-associated eruptions.
The central goal is to improve the skin without unnecessarily disrupting treatment for the underlying inflammatory disease. A coordinated plan between the dermatologist and prescribing clinician can help balance these priorities.